Copy Number Variations Found in Patients with a Corpus Callosum Abnormality and Intellectual Disability

[1]  D. MacGregor,et al.  Corpus callosum abnormalities: neuroradiological and clinical correlations , 2016, Developmental medicine and child neurology.

[2]  J. Rosenfeld,et al.  Novel features of 3q29 deletion syndrome: Results from the 3q29 registry , 2016, American journal of medical genetics. Part A.

[3]  B. Kamien,et al.  A familial 7q36.3 duplication associated with agenesis of the corpus callosum , 2015, American journal of medical genetics. Part A.

[4]  R. Frausto,et al.  Posterior polymorphous corneal dystrophy 3 is associated with agenesis and hypoplasia of the corpus callosum , 2014, Vision Research.

[5]  E. Palmer,et al.  Agenesis of the corpus callosum: A clinical approach to diagnosis , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.

[6]  A James Barkovich,et al.  Clinical, genetic and imaging findings identify new causes for corpus callosum development syndromes. , 2014, Brain : a journal of neurology.

[7]  Joseph T. Glessner,et al.  Both Rare and De Novo Copy Number Variants Are Prevalent in Agenesis of the Corpus Callosum but Not in Cerebellar Hypoplasia or Polymicrogyria , 2013, PLoS genetics.

[8]  A. Afenjar,et al.  Novel comprehensive diagnostic strategy in Pitt–Hopkins syndrome: Clinical score and further delineation of the TCF4 mutational spectrum , 2012, Human mutation.

[9]  Sixto García-Miñaur,et al.  Characterization of a 8q21.11 microdeletion syndrome associated with intellectual disability and a recognizable phenotype. , 2011, American journal of human genetics.

[10]  C. Ruivenkamp,et al.  Genomic and clinical characteristics of six patients with partially overlapping interstitial deletions at 10p12p11 , 2011, European Journal of Human Genetics.

[11]  S. Cavani,et al.  A 12.4 Mb direct duplication in 19q12-q13 in a boy with cardiac and CNS malformations and developmental delay , 2011, Journal of Applied Genetics.

[12]  F. Quintero-Rivera,et al.  Autistic and psychiatric findings associated with the 3q29 microdeletion syndrome: Case report and review , 2010, American journal of medical genetics. Part A.

[13]  J. Clayton-Smith,et al.  Identification of genomic loci contributing to agenesis of the corpus callosum , 2010, American journal of medical genetics. Part A.

[14]  Leslie G Biesecker,et al.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. , 2010, American journal of human genetics.

[15]  N. Nukina,et al.  A Functional Null Mutation of SCN1B in a Patient with Dravet Syndrome , 2009, The Journal of Neuroscience.

[16]  G. Berx,et al.  The role of the ZEB family of transcription factors in development and disease , 2009, Cellular and Molecular Life Sciences.

[17]  A. Barkovich,et al.  Variability of Homotopic and Heterotopic Callosal Connectivity in Partial Agenesis of the Corpus Callosum: A 3T Diffusion Tensor Imaging and Q-Ball Tractography Study , 2008, American Journal of Neuroradiology.

[18]  G. Shaw,et al.  Agenesis of the corpus callosum in California 1983–2003: A population‐based study , 2008, American journal of medical genetics. Part A.

[19]  Uwe Heinrich,et al.  Agenesis and dysgenesis of the corpus callosum: Clinical, genetic and neuroimaging findings in a series of 41 patients , 2008, American journal of medical genetics. Part A.

[20]  P. Lapunzina,et al.  Direct tandem duplication in chromosome 19q characterized by array CGH. , 2008, European journal of medical genetics.

[21]  R. Tervo,et al.  Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication , 2008, Molecular Cytogenetics.

[22]  C. Fuster,et al.  Duplication 19q13-qter and deletion 19p13-pter arising from an inversion (19)(p13.3q13.3) of maternal origin. , 2006, European journal of medical genetics.

[23]  C. Gélinas,et al.  A molecular insight of Hes5‐dependent inhibition of myelin gene expression: old partners and new players , 2006, The EMBO journal.

[24]  Gail P Jarvik,et al.  Reporting genetic results in research studies: Summary and recommendations of an NHLBI working group , 2006, American journal of medical genetics. Part A.

[25]  B. D. de Vries,et al.  3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. , 2005, American journal of human genetics.

[26]  L. W. Wang,et al.  Major brain lesions detected on sonographic screening of apparently normal term neonates , 2004, Neuroradiology.

[27]  Lori L. Isom,et al.  Mice Lacking Sodium Channel β1 Subunits Display Defects in Neuronal Excitability, Sodium Channel Expression, and Nodal Architecture , 2004, The Journal of Neuroscience.

[28]  Eric C. Lai,et al.  Notch signaling: control of cell communication and cell fate , 2004, Development.

[29]  C. Adamsbaum,et al.  Agenesis of corpus callosum: prenatal diagnosis and prognosis , 2003, Child's Nervous System.

[30]  B. Moore,et al.  Quantitative Morphology of the Corpus Callosum in Children With Neurofibromatosis and Attention-Deficit Hyperactivity Disorder , 2000, Journal of child neurology.

[31]  B. Barres,et al.  Notch Receptor Activation Inhibits Oligodendrocyte Differentiation , 1998, Neuron.

[32]  J. Bodensteiner,et al.  Evaluation of the child with idiopathic mental retardation. , 1992, Pediatric clinics of North America.

[33]  J. Grogono.  Children with Agenesis of the Corpus Callosum , 1968, Developmental medicine and child neurology.

[34]  M. Lavorgna,et al.  A new case of partial trisomy 19q (ql3.2-÷qter) owing to an unusual maternal translocation , 2022 .